Developing biomarkers to monitor menopause in women
Development of Biomarkers for Monitoring Menopause in Women
This study is trying to find new blood markers that can help track menopause in women by looking at different stages of their reproductive health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 20 Years and up |
| Sex | Female |
| Sponsor | Fu Jen Catholic University Hospital Academic / other |
| Locations | 1 site (New Taipei City) |
| Trial ID | NCT06852755 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women by analyzing peripheral blood samples from 100 participants across three groups: reproductive, perimenopausal, and postmenopausal. The study will utilize both qualitative and quantitative analyses to assess mitochondrial quality and quantity, identifying potential biomarkers through metabolomics. This innovative approach seeks to address unmet needs in women's health management during menopause, particularly in monitoring psychological changes and systemic health issues associated with this transition.
Who should consider this trial
Good fit: Ideal candidates for this study are biological females aged 20 years and older who are in different stages of menopause.
Not a fit: Patients with cancer, acute or chronic infections, known chronic illnesses, or those undergoing female hormone therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a novel monitoring system for women's health during menopause, improving management of associated conditions.
How similar studies have performed: While there have been studies focusing on menopausal symptoms, the specific approach of developing mitochondrial biomarkers for monitoring menopause is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biological female, age order than 20 years old. Exclusion Criteria: * Person with cancer. * Person with any known acute or chronic infection. * Person with known chronic illness under follow up or treatment. * Pregnancy, one year withing delivery, under breast feeding, or three months within breast feeding. * Under any female horemone therapy.
Where this trial is running
New Taipei City
- Fu Jen Catholic University Hospital, Fu Jen Catholic University — New Taipei City, Taiwan (Recruiting)
Study contacts
- Study coordinator: Shu-Yu Liu
- Email: syliu0123@outlook.com
- Phone: +886910893512
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.